Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D LARSEN

Showing results (621-630 of 666) with videos related to

Pageof 67
Sort By:
Nature Communications|January 6, 2015
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint controlDitte Kjærsgaard Klein, Saskia Hoffmann, Johanna K Ahlskog, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2007
Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorptionJeffrey A Pfefferkorn, Scott D Larsen, Chad Van Huis, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-designScott D Larsen, Toni-Jo Poel, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
European Journal of Medicinal Chemistry|December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapyBrandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 10, 2024
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort studyStine K Christensen, Mette L Winther, Ida J Laursen, et al.
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
Genome|September 12, 2001
Soybean genomic survey: BAC-end sequences near RFLP and SSR markersL F Marek, J Mudge, L Darnielle, et al.
Nature Genetics|March 27, 2019
Author Correction: Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesisAlexander Rauch, Anders K Haakonsson, Jesper G S Madsen, et al.
Pageof 67

Showing results (621-630 of 666) with videos related to

Sort By:
Pageof 67
Nature Communications|January 6, 2015
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint controlDitte Kjærsgaard Klein, Saskia Hoffmann, Johanna K Ahlskog, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2007
Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorptionJeffrey A Pfefferkorn, Scott D Larsen, Chad Van Huis, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-designScott D Larsen, Toni-Jo Poel, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
European Journal of Medicinal Chemistry|December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapyBrandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 10, 2024
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort studyStine K Christensen, Mette L Winther, Ida J Laursen, et al.
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
Genome|September 12, 2001
Soybean genomic survey: BAC-end sequences near RFLP and SSR markersL F Marek, J Mudge, L Darnielle, et al.
Nature Genetics|March 27, 2019
Author Correction: Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesisAlexander Rauch, Anders K Haakonsson, Jesper G S Madsen, et al.
Pageof 67